Ayala Pharmaceuticals Inc (ADXS)

[cab033]

Actually what doesnt make sense is thinking this will be BO anytime soon. Everything else makes perfect sense.

- The BOD and management Does care about money, just look at the proxy (30M new shares. After issued would provide funding for 12-24 months).

- The retention plan was to prevent DO from recruiting employees, assuming he was fired, he could do that as payback, smart move by the BOD to prevent further negative attention.

- Lack of news because nothing to announce. (per business plan expect news 1H 2018 at a major conference, no major conferences occured yet, assume ASCO to be conservative)

- EMA not filed yet but expected timeframe has not expired yet either. Give them a bit more time and I am sure they will get it filed within the expected window).

- No perm CEO because funding has not been addressed yet. After new shares are issued a perm CEO will be announced shortly after.

- No talk from company on BO, partnerships, or franchise purchase because... No interest yet. Gotta give it more time to play out.

- Sub $3 stock because (all of the above) plus Institution bailed pretty hard after DO left and after sub $5 happened. Also they have been net selling the last 4 Q's in a row, combined with short count increase equals more selling pressure with minimal buying pressure. It only takes 1 major investor to the potential here and this would rise, but smart money must not be as smart as this MB.